Tao Ling

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Chemotherapy Induced

Knee Osteoarthritis

Top Venues

Technology in cancer research & treatment

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Lianghui Zhang, Lingli Huang, Zhixian Liu, Tao Ling
Immune Checkpoint Inhibitor Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Review and Meta-Analysis. Technology in cancer research & treatment 23 (2024)
Lianghui Zhang, Lingli Huang, Zhixian Liu, Tao Ling
Immune Checkpoint Inhibitor Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Review and Meta-Analysis. Technology in cancer research & treatment 23 (2024)
Lianghui Zhang, Lingli Huang, Zhixian Liu, Tao Ling
Immune Checkpoint Inhibitor Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Review and Meta-Analysis. Technology in cancer research & treatment 23 (2024)
Tao Ling, Jiao Jiao Li, Rui-Juan Xu, Bin Wang, Wei-Hong Ge
Topical Diclofenac Solution for Osteoarthritis of the Knee: An Updated Meta-Analysis of Randomized Controlled Trials. BioMed research international 2020 (2020)